Skip to main content

Alexion Pharmaceuticals, Inc.

ALXNDelisted Jul 21, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0000899866

Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.

Q2 2026 vs. Q1 2026

How the institutions holding Alexion Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of ALXN: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders20−2
Shares16.4K0−16.4K (−100.0%)
Value$2.16M$0−$2.16M (−100.0%)

New holders (0)

Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

None.

Sold out (2)

Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ALXN in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Kentucky Retirement Systems16,188$2.15M
Accent Capital Management, LLC193$6.82K